Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease | |
Gao, Caifang[1]; Liu, Lijuan[1,2,3]; Zhou, Yangyang[1]; Bian, Zhaoxiang[4]; Wang, Shengpeng[1,5]; Wang, Yitao[1] | |
2019 | |
卷号 | 14 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000471901100001 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4720383 |
专题 | 成都中医药大学 |
作者单位 | 1.[1]Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Ave Univ, Taipa, Macao, Peoples R China 2.[2]Guangdong Macau Tradit Chinese Med Technol Ind Pk, PU Innovat Inst Chinese Med Sci, Hengqin New Area, Zhuhai, Peoples R China 3.[3]Chengdu Univ Tradit Chinese Med, Coll Pharm, Chengdu, Sichuan, Peoples R China 4.[4]Hong Kong Baptist Univ, Sch Chinese Med, Kowloon, Hong Kong, Peoples R China 5.[5]Leiden Univ, European Ctr Chinese Med & Nat Cpds, Inst Biol, Leiden, Netherlands |
推荐引用方式 GB/T 7714 | Gao, Caifang[1],Liu, Lijuan[1,2,3],Zhou, Yangyang[1],et al. Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease[J],2019,14. |
APA | Gao, Caifang[1],Liu, Lijuan[1,2,3],Zhou, Yangyang[1],Bian, Zhaoxiang[4],Wang, Shengpeng[1,5],&Wang, Yitao[1].(2019).Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease.,14. |
MLA | Gao, Caifang[1],et al."Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease".14(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论